Abbott Laboratories will invest $40 million over five years into its highly-scrutinized Michigan plant to resolve stockholder ...
Zacks Investment Research on MSN
Is trending stock Abbott Laboratories (ABT) a buy now?
Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...
Opening arguments begin in first Illinois trial against Abbott over its formula for premature babies
Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...
StockStory.org on MSN
Q4 earnings highs and lows: Abbott Laboratories (NYSE:ABT) vs the rest of the medical devices & supplies - diversified stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Abbott Laboratories’ modelled fair value has been adjusted only fractionally, from US$133.39 to US$133.33 per share, keeping the core price target effectively stable in absolute terms. That tiny shift ...
Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...
"I think this is a little bit of an overreaction. Of course, we are all over this," Ford said. "We're focused on this, but the fundamentals of the entire rest of the company are pretty much intact, ...
Abbott Laboratories is scheduled to report fourth-quarter earnings before the market opens Thursday. Here is what you need to know: NET INCOME: The healthcare-products maker is projected to post a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results